David Larsen
Stock Analyst at BTIG
(0.26)
# 4,585
Out of 5,090 analysts
588
Total ratings
36.7%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintained: Hold | n/a | $36.88 | - | 26 | Oct 30, 2026 | |
| TDOC Teladoc Health | Reiterated: Hold | n/a | $8.73 | - | 21 | Oct 28, 2026 | |
| DRIO DarioHealth | Initiated Coverage: Buy | $6 | $3.31 | +81.26% | 1 | Oct 27, 2026 | |
| IQV IQVIA Holdings | Rated: Hold | n/a | $275.06 | - | 12 | Oct 27, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $25 → $26 | $18.29 | +42.15% | 34 | Oct 13, 2026 | |
| DCGO DocGo | Reiterated: Hold | n/a | $0.2731 | - | 20 | Sep 30, 2026 | |
| OMDA Omada Health | Rated: Buy | $35 | $19.65 | +78.12% | 3 | Sep 11, 2026 | |
| DH Definitive Healthcare | Rated: Hold | n/a | $1.12 | - | 10 | Sep 3, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $115 | $101.36 | +13.46% | 32 | Aug 28, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 | $32.00 | +71.88% | 8 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $310.34 | +9.56% | 14 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.79 | - | 26 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $110 | $86.44 | +27.26% | 16 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $13.64 | +32.01% | 8 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.67 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $37.69 | +32.66% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $36.62 | +77.50% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $22.00 | +59.13% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $9 | $2.32 | +287.93% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.98 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $60.22 | +49.45% | 19 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $40 | $28.40 | +40.85% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $4.25 | +88.24% | 51 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $6.65 | +35.34% | 12 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.63 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.20 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $85.94 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $330.53 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $376.10 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $90.33 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $251.09 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $9 | $0.233 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $980.88 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.75 | n/a | 8 | Jun 19, 2017 |
Omnicell
Oct 30, 2026
Maintained: Hold
Price Target: n/a
Current: $36.88
Upside: -
Teladoc Health
Oct 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.73
Upside: -
DarioHealth
Oct 27, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $3.31
Upside: +81.26%
IQVIA Holdings
Oct 27, 2026
Rated: Hold
Price Target: n/a
Current: $275.06
Upside: -
Cryoport
Oct 13, 2026
Reiterated: Buy
Price Target: $25 → $26
Current: $18.29
Upside: +42.15%
DocGo
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2731
Upside: -
Omada Health
Sep 11, 2026
Rated: Buy
Price Target: $35
Current: $19.65
Upside: +78.12%
Definitive Healthcare
Sep 3, 2026
Rated: Hold
Price Target: n/a
Current: $1.12
Upside: -
HealthEquity
Aug 28, 2026
Reiterated: Buy
Price Target: $115
Current: $101.36
Upside: +13.46%
Medline
Aug 27, 2026
Reiterated: Buy
Price Target: $55
Current: $32.00
Upside: +71.88%
Aug 26, 2026
Reiterated: Buy
Price Target: $340
Current: $310.34
Upside: +9.56%
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.79
Upside: -
Aug 19, 2026
Reiterated: Buy
Price Target: $100 → $110
Current: $86.44
Upside: +27.26%
Aug 19, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $13.64
Upside: +32.01%
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $29.67
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $37.69
Upside: +32.66%
Aug 9, 2026
Reiterated: Buy
Price Target: $65
Current: $36.62
Upside: +77.50%
Aug 9, 2026
Reiterated: Buy
Price Target: $35
Current: $22.00
Upside: +59.13%
Aug 6, 2026
Rated: Buy
Price Target: $10 → $9
Current: $2.32
Upside: +287.93%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.98
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: $90
Current: $60.22
Upside: +49.45%
Jul 24, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $28.40
Upside: +40.85%
Jul 16, 2026
Rated: Buy
Price Target: $8
Current: $4.25
Upside: +88.24%
Jul 15, 2026
Reiterated: Buy
Price Target: $9
Current: $6.65
Upside: +35.34%
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $33.63
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $4.20
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $85.94
Upside: -
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $330.53
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $376.10
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $90.33
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $251.09
Upside: n/a
Oct 31, 2018
Reiterated: Hold
Price Target: $17 → $9
Current: $0.233
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $980.88
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.75
Upside: n/a